Pharmacological characterisation of melatonin mt1 receptor-mediated stimulation of [35S]-GTPγS binding

Biochemical Pharmacology

Volumn 56, Issue 9, 1998, Pages 1167-1174

  Beresford, Isabel J M ^a   Harvey, Fiona J ^a   Hall, David A ^a   Giles, Heather ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

G protein; Luzindole; Melatonin; mt1 receptor; Pertussis toxin; 35S GTP S

Indexed keywords

2 IODOMELATONIN; 6 CHLOROMELATONIN; 6 HYDROXYMELATONIN; AGOMELATINE; GR 135531; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; LUZINDOLE; MAGNESIUM CHLORIDE; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; N ACETYLSEROTONIN; N [2 (2,3,7,8 TETRAHYDRO 1H FURO[2,3 G]INDOL 1 YL)ETHYL]ACETAMIDE; PERTUSSIS TOXIN; RADIOLIGAND; SODIUM CHLORIDE; SULFUR 35; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; LIGAND BINDING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; STIMULATION;

EID: 0031796260     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00254-8     Document Type: Article

References (36)

1. Dubocovich ML, Cardinali DP, Guardiola-Lemaitre B, Hagan RM, Krause DN, Sugden D, Vanhoutte PM and Yocca FD, Melatonin Receptors. The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media, London (in press).
2. Arendt J, Melatonin and the Mammalian Pineal Gland. Chapman and Hall, London, 1995.
3. Reppert SM, Weaver DR and Godson C, Melatonin receptors step into the light: Cloning and classification of subtypes. TIPS 17: 100-102, 1996.
4. Morgan PJ, Barrett P, Howell HE and Helliwell R, Melatonin receptors: Localization, molecular pharmacology and physiological significance. Neurochem Int 24: 101-146, 1994.
5. Reppert SM, Weaver DR and Ebisawa T, Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185, 1994.
6. 1B melatonin receptor. Proc Natl Acad Sci USA 92: 8734-8738, 1995.
7. 1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol Pharmacol 50: 166-174, 1996.
8. Vanecek J, Melatonin inhibits increase of intracellular calcium and cyclic AMP in neonatal rat pituitary via independent pathways. Mol Cell Endocrinol 107: 149-153, 1995.
9. 1A melatonin receptor is coupled to parallel signal transduction pathways. Endocrinol 138: 397-404, 1997.
10. Morgan PJ, Davidson G, Lawson W and Barrett P, Both pertussis toxin-sensitive and -insensitive G-proteins link melatonin receptor to inhibition of adenylate cyclase in the ovine pars tuberalis. J Neuroendocrinol 2: 773-776, 1990.
11. Morgan PJ, Barrett P, Hazlerigg D, Milligan G, Lawson W, MacLean A and Davidson G, Melatonin receptors couple through a cholera toxin-sensitive mechanism to inhibit cyclic AMP in the ovine pituitary. J Neuroendocrinol 7: 361-369, 1995.
12. z proteins. FEBS Letts 372: 99-102, 1995.
13. Ebisawa T, Karne S, Lerner MR and Reppert SM, Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 91: 6133-6137, 1994.
14. 35S]thio)triphosphate binding. Mol Pharmacol 44: 115-123, 1993.
15. 35S]-GTPγS binding mediated by human muscarinic ml-m4 receptors: Antagonist studies. Br J Pharmacol 109: 1120-1127, 1993.
16. 2long dopamine receptors expressed in recombinant cells. Br J Pharmacol 118: 1544-1550, 1996.
17. 35S]guanosine-5′-O-(3-thio)triphosphate binding: Agonist potencies and the influence of sodium chloride on intrinsic activity. Mol Pharmacol 51: 1060-1069, 1997.
18. 35S]-GTPγS binding. Br J Pharmacol 121: 1203-1209, 1997.
19. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
20. De Lean A, Munson PJ and Rodbard D, Simultaneous analysis of families of sigmoidal curves: Applications to bioassay, radio-ligand assay, and physiological dose-response curves. Am J Physiol 235: E97-E102, 1977.
21. 2 receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol 86: 581-587, 1985.
22. Lew MJ and Angus JA, Analysis of competitive agonist-antagonist interactions by non-linear regression. TIPS 16: 328-337, 1995.
23. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
24. 1B receptors. Br J Pharmacol 120: 361P, 1997.
25. Dubocovich ML, Melatonin receptors: Are there multiple subtypes. TIPS 16: 50-56, 1995.
26. 2 binding sites. Eur J Pharmacol 301: 159-168, 1996.
27. Dubocovich ML, Luzindole (N-0074): A novel melatonin receptor antagonist. J Pharmacol Exp Ther 246: 902-910, 1988.
28. Yous S, Andrieux J, Howell HE, Morgan PJ, Renard P, Pfeiffer B, Lesieur D and Guardiola-Lemaitre B, Novel naphthalenic ligands with high affinity for the melatonin receptor. J Med Chem 35: 1484-1486, 1992.
29. Beresford IJM, Browning C, Starkey SJ, Brown J, Foord SM, Coughlan J, North PC, Dubocovich ML and Hagan RM, GR196429: A nonindolic agonist at high-affinity melatonin receptors. J Pharmacol Exp Therap 285: 1239-1245, 1998.
30. 4.4 receptors: Actions of antiparkinsonian and antipsychotic agents. J Pharmacol Exp Ther 282: 181-191, 1997.
31. 1 presynaptic heteroreceptor. NS Arch Pharmacol 355: 365-375, 1997.
32. 1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635. Br J Pharmacol 120: 737-739, 1997.
33. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47: 848-854, 1995.
34. β1. J Biol Chem 267: 8081-8088, 1992.
35. z, a guanine nucleotide-binding protein with unique biochemical properties. J Biol Chem 265: 2383-2390, 1990.
36. Higashijima T, Ferguson KM, Sternweis PC, Ross EM, Smigel MD and Gilman AG, The effect of activating ligands on the intrinsic fluorescence of guanine-nucleotide-binding regulatory proteins. J Biol Chem 262: 752-756, 1987.